Key result
Estimated pulse wave velocity (ePWV) demonstrated a strong independent association with directly measured carotid-femoral pulse wave velocity and brachial-ankle pulse wave velocity.
Why the study?
Indirect estimates of pulse wave velocity have been proposed as an alternative for PWV assessment in clinical practice, but their validity and clinical applicability remain uncertain.
Do indirect 24-hour blood pressure arterial stiffness indexes (ePWV, 24h-PP, EVAAS) accurately correlate with directly measured pulse wave velocity in adults?
Observational (n=4,206)
Yes
Do indirect 24-hour blood pressure arterial stiffness indexes (ePWV, 24h-PP, EVAAS) accurately correlate with directly measured pulse wave velocity in adults?
Answers are grounded in this paper and cite their sources.
Estimated pulse wave velocity (ePWV) derived from 24-hour ambulatory blood pressure monitoring can serve as a valid non-invasive surrogate marker for arterial stiffness, particularly in individuals without major cardiometabolic comorbidities.
Background: Indirect estimates of pulse wave velocity (PWV) have been proposed as a feasible alternative for PWV assessment in clinical practice; however, their validity and clinical applicability remain uncertain. This study aimed to evaluate the relationships between indirect measures of arterial stiffness and directly measured PWV to determine their potential utility in clinical settings. Methods: In this multicentre, international study, data from 4,206 individuals from Brazil, Greece, Korea, and Australia were analysed. The relationships between estimated PWV (ePWV), 24-hour (24h)-pulse pressure (PP), Early Vascular Aging Ambulatory Score (EVAAS), and carotid-femoral (cf-PWV) and/or brachial-ankle (ba-PWV) PWV were assessed through correlation and multivariate linear regression analyses. Subgroup-specific associations were also examined. Results: < 0.001). 24h-PP and EVAAS showed moderate associations with both cf-PWV and ba-PWV. Subgroup analyses indicated that ePWV correlated more strongly with both cf-PWV and ba-PWV in individuals without traditional cardiovascular risk factors. Conclusions: ePWV may be used as a surrogate marker for arterial stiffness, particularly in individuals without major cardiometabolic comorbidities. Although 24h-PP and EVAAS are also associated with PWV, their clinical utility varies across subgroups. Future research should explore their role in improving cardiovascular risk prediction and guiding personalized treatment strategies for vascular aging. Trial Registration: PROSPERO Identifier: CRD420250618863.
No takes yet. Share an insight, caveat, or question.
Kakaletsis et al. (2025) conducted an observational in Hypertension and cardiovascular risk (n=4,206). Estimated pulse wave velocity (ePWV) was evaluated on Association between estimated pulse wave velocity (ePWV) and directly measured carotid-femoral pulse wave velocity (cf-PWV) (β = 0.599, 95% CI 0.495 to 0.703, p=< 0.001). Estimated pulse wave velocity (ePWV) demonstrated a strong independent association with directly measured carotid-femoral pulse wave velocity and brachial-ankle pulse wave velocity.
Synapse has enriched 10 related papers. Consider them for comparative context: